טוען...
Expression of the Receptor for Hyaluronic Acid Mediated Motility (RHAMM) in Endometrial Cancer is Associated with Adverse Histologic Parameters and Tumor Progression
Endometrial cancer is one of the most common gynecologic malignancies worldwide. Only two agents have been approved by Food and Drug Administration for endometrial cancer since 1971. There is a need to identify molecular targets to treat advanced endometrial cancer. The receptor for hyaluronan-media...
שמור ב:
| הוצא לאור ב: | Appl Immunohistochem Mol Morphol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7546253/ https://ncbi.nlm.nih.gov/pubmed/30920393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAI.0000000000000763 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|